Abstract

Background: Congenital Heart Disease (CHD) constitutes a significant cause of morbidity and mortality in newborns. Identifying CHD prenatally and understanding associated risk factors can aid in early diagnosis, intervention, and postnatal management. This study aims to assess risk factors for CHD using prenatal fetal echocardiography (FE) and investigate their correlation with postnatal diagnoses.

Patients and Methods: In this study, we included 993 pregnant women presenting to the pediatric cardiology outpatient clinic between December 2018 and December 2020, considered at risk for CHD. We retrospectively evaluated the cases’ postnatal echocardiography data with detected CHD during fetal echocardiography.

Results: The average age of the patients was 29.8±5.7, and the mean gestational week was 23.61±3.9. Among the pregnant women, 253 (25.47%) were primiparous, 740 (74.53%) were multiparous, 103 cases (9.32%) involved multiple pregnancies, and 259 (26.08%) had chronic diseases. The most common reason for fetal echocardiography referral was the suspicion of CHD in fetuses with dysmorphic findings detected during obstetric ultrasonography. Among the cases, 329 (33.1%) were classified as low-risk, while 664 (66.9%) as high-risk. Among all patients, the most commonly observed prenatal CHD were Ventricular Septal Defects (VSD) (8.2%), Hydrops Fetalis (6.1%), and large Atrial Septal Defects (ASD) (3.9%). The overall prevalence of CHD was 31.6%. The accuracy of postnatal echocardiography in confirming the diagnoses made with fetal echocardiography was 94%.

Conclusion: Prenatal diagnosis of congenital heart diseases is crucial for planning prenatal and postnatal management and providing families with the option of pregnancy termination in severe anomalies. Fetal echocardiography has shown significant potential for early diagnosis of CHD, even in low-risk fetuses, and its inclusion in routine prenatal screenings by increasing the number of experienced specialists and centers could play a crucial role in reducing CHD-related mortality and morbidity rates.

Keywords: Fetal echocardiography, congenital heart diseases, prenatal diagnosis, high risk pregnancy

Copyright and license

Copyright © 2023 The author(s). This is an open-access article published by Aydın Pediatric Society under the terms of the Creative Commons Attribution License (CC BY) which permits unrestricted use, distribution, and reproduction in any medium or format, provided the original work is properly cited.

How to cite

1.
Yıldız K, Bayam YS, Bardak H, Akçura YD, Bozyer HE, Çeliktepe V, et al. Assessment of risk factors for congenital heart disease through prenatal fetal echocardiography and the correlation with postnatal diagnoses. Trends in Pediatrics. 2023;4(3):205-209. https://doi.org/10.59213/TP.2023.90522

References

  1. Hoffman JI, Christianson R. Congenital heart disease in a cohort of 19,502 births with long-term follow-up. Am J Cardiol. 1978;42:641-7. https://doi.org/10.1016/0002-9149(78)90635-5
  2. Ferencz C, Rubin JD, McCarter RJ, et al. Congenital heart disease: prevalence at livebirth. The Baltimore-Washington Infant Study. Am J Epidemiol. 1985;121:31-6. https://doi.org/10.1093/oxfordjournals.aje.a113979
  3. Young ID, Clarke M. Lethal malformations and perinatal mortality: a 10 year review with comparison of ethnic differences. Br Med J (Clin Res Ed). 1987;295:89-91. https://doi.org/10.1136/bmj.295.6590.89
  4. Xu Y, Hu YL, Ru T, Gu Y, Yang Y, Dai CY. Importance of "Guidelines for performing fetal cardiac scan" in prenatal screening for fetal congenital heart disease. Zhonghua Fu Chan Ke Za Zhi. 2009;44:103-7.
  5. Stümpflen I, Stümpflen A, Wimmer M, Bernaschek G. Effect of detailed fetal echocardiography as part of routine prenatal ultrasonographic screening on detection of congenital heart disease. Lancet. 1996;348:854-7. https://doi.org/10.1016/S0140-6736(96)04069-X
  6. Moon-Grady AJ, Donofrio MT, Gelehrter S, et al. Guidelines and Recommendations for Performance of the Fetal Echocardiogram: An Update from the American Society of Echocardiography. J Am Soc Echocardiogr. 2023;36:679-723. https://doi.org/10.1016/j.echo.2023.04.014
  7. Zhang YF, Zeng XL, Zhao EF, Lu HW. Diagnostic Value of Fetal Echocardiography for Congenital Heart Disease: A Systematic Review and Meta-Analysis. Medicine (Baltimore). 2015;94:e1759. https://doi.org/10.1097/MD.0000000000001759
  8. Ozkutlu S, Akça T, Kafali G, Beksaç S. The results of fetal echocardiography in a tertiary center and comparison of low- and high-risk pregnancies for fetal congenital heart defects. Anadolu Kardiyol Derg. 2010;10:263-9. https://doi.org/10.5152/akd.2010.068
  9. Schleich JM, Almange C. Fetal echocardiography. Arch Pediatr. 1998;5:1236-45. https://doi.org/10.1016/s0929-693x(98)81243-8
  10. Donofrio MT, Moon-Grady AJ, Hornberger LK, et al. Diagnosis and treatment of fetal cardiac disease: a scientific statement from the American Heart Association. Circulation. 2014;129:2183-242. https://doi.org/10.1161/01.cir.0000437597.44550.5d
  11. Ozbarlas N, Erdem S, Küçükosmanoğlu O, et al. Prevalence and distribution of structural heart diseases in high and low risk pregnancies. Anadolu Kardiyol Derg. 2011;11:125-30. https://doi.org/10.5152/akd.2011.032
  12. Todros T, Faggiano F, Chiappa E, Gaglioti P, Mitola B, Sciarrone A. Accuracy of routine ultrasonography in screening heart disease prenatally. Gruppo Piemontese for Prenatal Screening of Congenital Heart Disease. Prenat Diagn. 1997;17:901-6.
  13. Mohammed NB, Chinnaiya A. Evolution of foetal echocardiography as a screening tool for prenatal diagnosis of congenital heart disease. J Pak Med Assoc. 2011;61:904-9.
  14. Barati M, Nasehi N, Aberoumand S, Najafian M, Emami Moghadam A. Factors causing timely referral for fetal echocardiography in the final diagnosis of congenital heart malformations: a cross-sectional study. Int J Reprod Biomed. 2022;20:477-482. https://doi.org/10.18502/ijrm.v20i6.11443
  15. Boughman JA, Berg KA, Astemborski JA, et al. Familial risks of congenital heart defect assessed in a population-based epidemiologic study. Am J Med Genet. 1987;26:839-49. https://doi.org/10.1002/ajmg.1320260411
  16. Ferencz C, Neill CA, Boughman JA, Rubin JD, Brenner JI, Perry LW. Congenital cardiovascular malformations associated with chromosome abnormalities: an epidemiologic study. J Pediatr. 1989;114:79-86. https://doi.org/10.1016/s0022-3476(89)80605-5
  17. Smythe JF, Copel JA, Kleinman CS. Outcome of prenatally detected cardiac malformations. Am J Cardiol. 1992;69:1471-4. https://doi.org/10.1016/0002-9149(92)90903-c
  18. Shikany AR, Landis BJ, Parrott A, et al. A Comprehensive Clinical Genetics Approach to Critical Congenital Heart Disease in Infancy. J Pediatr. 2020;227:231-8.e14. https://doi.org/10.1016/j.jpeds.2020.07.065
  19. Calzolari E, Barisic I, Loane M, et al. Epidemiology of multiple congenital anomalies in Europe: a EUROCAT population-based registry study. Birth Defects Res A Clin Mol Teratol. 2014;100:270-6. https://doi.org/10.1002/bdra.23240
  20. Best KE, Tennant PWG, Rankin J. Survival, by Birth Weight and Gestational Age, in Individuals With Congenital Heart Disease: A Population-Based Study. J Am Heart Assoc. 2017;6:e005213. https://doi.org/10.1161/JAHA.116.005213